For many brain diseases, particularly in psychiatry, we lack clinical tests for differential diagnosis and cannot predict optimal treatment for individual patients. This presentation outlines a translational neuromodeling framework which aims at establishing “computational assays” for inferring subject-specific mechanisms of brain disease from non-invasive measures of behaviour and neuronal activity.
[more]
